BioWorld

Aug. 14, 2008

View Archived Issues

Talecris Opts for $3.1B Merger Instead of IPO

Talecris Biotherapeutics Inc. said it is being acquired by Australian firm CSL Ltd. in a $3.1 billion cash merger that would form one of the largest plasma-derived therapeutics firms worldwide. (BioWorld Today) Read More

Genentech Rejects Roche Offer, as Biotech's Shares Near $100

Read More

Immune Suppressant Can Stimulate Immune System

Read More

Anthera Raises $19M to Boost Work in Anti-inflammatories

Read More

Clinic Roundup

Read More

Other News To Note

Read More

Earnings Roundup

Read More